Natera, Inc. (NASDAQ:NTRA) was downgraded by ValuEngine from a “sell” rating to a “strong sell” rating in a report issued on Monday, July 24th.
A number of other research firms also recently commented on NTRA. Zacks Investment Research downgraded Natera from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th. Canaccord Genuity lifted their target price on Natera from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Wednesday, May 10th. Four research analysts have rated the stock with a sell rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $14.45.
Shares of Natera (NASDAQ NTRA) opened at 11.19 on Monday. The company’s market cap is $595.57 million. The stock’s 50 day moving average is $9.95 and its 200-day moving average is $9.62. Natera has a one year low of $7.35 and a one year high of $12.95.
Natera (NASDAQ:NTRA) last issued its quarterly earnings results on Tuesday, August 8th. The medical research company reported ($0.52) earnings per share for the quarter, hitting the consensus estimate of ($0.52). The business had revenue of $53.60 million during the quarter, compared to the consensus estimate of $50.57 million. Natera had a negative return on equity of 137.46% and a negative net margin of 62.64%. The company’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter last year, the company earned ($0.46) earnings per share. Equities research analysts expect that Natera will post ($2.03) earnings per share for the current year.
Several hedge funds have recently bought and sold shares of the stock. GSA Capital Partners LLP acquired a new stake in Natera during the fourth quarter worth approximately $121,000. Virtu KCG Holdings LLC acquired a new stake in Natera during the second quarter worth approximately $126,000. Russell Investments Group Ltd. acquired a new stake in Natera during the fourth quarter worth approximately $130,000. American International Group Inc. boosted its stake in Natera by 7.1% in the first quarter. American International Group Inc. now owns 16,065 shares of the medical research company’s stock worth $142,000 after buying an additional 1,068 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its stake in shares of Natera by 1.2% in the first quarter. Massachusetts Financial Services Co. MA now owns 16,118 shares of the medical research company’s stock valued at $143,000 after buying an additional 194 shares during the last quarter. Institutional investors and hedge funds own 59.86% of the company’s stock.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.